Evidence map›Paper›PMID 26081560›Full record

ArticleRNA (New York, N.Y.)2015

In vivo characterization of the Drosophila mRNA 3' end processing core cleavage complex.

Daniel Michalski, Mindy Steiniger

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel MichalskiDepartment of Biology, University of Missouri-St. Louis, St. Louis, Missouri 63121, USA.
Mindy SteinigerDepartment of Biology, University of Missouri-St. Louis, St. Louis, Missouri 63121, USA.
University of Missouri–St. Louis · US

Funding

The link between mRNA 3' end processing and siRNA biogenesis in DrosophilaR15GM107931 · NIGMS · UNIVERSITY OF MISSOURI-ST. LOUIS · PI STEINIGER, MINDY · 2013 to 2013
$330k
NIGMS NIH HHS R15 GM107931NIGMS NIH HHS R15GM107931
6 · The paper itself

Abstract

A core cleavage complex (CCC) consisting of CPSF73, CPSF100, and Symplekin is required for cotranscriptional 3' end processing of all metazoan pre-mRNAs, yet little is known about the in vivo molecular interactions within this complex. The CCC is a component of two distinct complexes, the cleavage/polyadenylation complex and the complex that processes nonpolyadenylated histone pre-mRNAs. RNAi-depletion of CCC factors in Drosophila culture cells causes reduction of CCC processing activity on histone mRNAs, resulting in read through transcription. In contrast, RNAi-depletion of factors only required for histone mRNA processing allows use of downstream cryptic polyadenylation signals to produce polyadenylated histone mRNAs. We used Dmel-2 tissue culture cells stably expressing tagged CCC components to determine that amino acids 272-1080 of Symplekin and the C-terminal approximately 200 amino acids of both CPSF73 and CPSF100 are required for efficient CCC formation in vivo. Additional experiments reveal that the C-terminal 241 amino acids of CPSF100 are sufficient for histone mRNA processing indicating that the first 524 amino acids of CPSF100 are dispensable for both CCC formation and histone mRNA 3' end processing. CCCs containing deletions of Symplekin lacking the first 271 amino acids resulted in dramatic increased use of downstream polyadenylation sites for histone mRNA 3' end processing similar to RNAi-depletion of histone-specific 3' end processing factors FLASH, SLBP, and U7 snRNA. We propose a model in which CCC formation is mediated by CPSF73, CPSF100, and Symplekin C-termini, and the N-terminal region of Symplekin facilitates cotranscriptional 3' end processing of histone mRNAs.

Indexed as

AnimalsCleavage And Polyadenylation Specificity FactorDrosophila melanogasterDrosophila ProteinsHistonesmRNA Cleavage and Polyadenylation FactorsMutationPolyadenylationRNA, MessengerTissue Culture TechniquesCleavage And Polyadenylation Specificity FactorCPSF100 protein, DrosophilaCPSF73 protein, DrosophilaDrosophila ProteinsHistonesmRNA Cleavage and Polyadenylation FactorsRNA, MessengerSym protein, DrosophilacotranscriptionalCPSF100CPSF73DrosophilamRNA 3′ end processingSymplekin

Identifiers

PMID26081560
PMCPMC4509931
OpenAlexW2162096808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.